Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Efficacy and Safety of HSK16149 Capsule Combined With L-carnitine Hydrochloride Tablets and Lipoic Acid Combined With L-carnitine Hydrochloride Tablets in Diabetic Peripheral Neuralgia Patients in China
Conditions
Interventions
HSK16149 20mg BID
Locations
1
China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Start Date
May 1, 2023
Primary Completion Date
April 30, 2024
Completion Date
May 1, 2024
Last Updated
November 8, 2023
NCT07285018
NCT06221241
NCT07377721
NCT06614322
NCT05177094
NCT04688671
Lead Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions